Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.06 - $1.67 $530 - $835
-500 Reduced 0.58%
85,600 $99,000
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $3,276 - $4,654
2,600 Added 3.11%
86,100 $145,000
Q3 2023

Nov 14, 2023

BUY
$1.61 - $2.54 $966 - $1,524
600 Added 0.72%
83,500 $151,000
Q2 2023

Aug 14, 2023

BUY
$1.14 - $1.95 $40,584 - $69,420
35,600 Added 75.26%
82,900 $154,000
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $4,680 - $8,541
3,900 Added 8.99%
47,300 $62,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $438 - $2,244
600 Added 1.4%
43,400 $135,000
Q2 2022

Aug 16, 2022

BUY
$2.2 - $4.2 $94,160 - $179,760
42,800 New
42,800 $102,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $16.3B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.